chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PT received second dose of Moderna COVID 19 vaccine 14 days after first dose according to Vaccine Card provided to SPC.  Encounters were confirmed in PTs military medical history through record on 20220627.
pt recv vax 6AUG97 & 13AUg97 pt c/o a generalized urticaria;
Reticular red rash starting within 24 hours of receiving vaccines. No other symptoms. No treatments.
Information has been received from a registered nurse referring to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions/allergies were not reported. On 07-JUL-2015 the patient was inadvertently vaccinated with an expired dose of M-M-R II, lot # J007929 with expiry date 28-JUN-2015 (dose and route were not reported). No adverse effects were reported. Additional information has been requested.
Migraine headache for roughly 15 hours, redness/itching/pain on triceps area below injection site, malaise, other COVID-19 like symptoms
An hour and thirty minutes after getting vaccine I got nauseous, and having black out, pouring sweat, dizzy, almost like motion sickness. I was taken to the ER. They gave me IV fluids, medication for nausea, and dizziness. I'm having joint pain, fatigue, soreness in my arm.
Immediately following vaccine administration patient experienced shakiness, black out feeling, sweats, nausea, and faintness.  We tried ammonia inhalants to keep her from fainting and also gave her some water to drink.  Nurse practioner checked her blood pressure and was low 85/40's x 3.  Patient refused blood sugar check by pharmacist b/c she didn't want "any more needles." We called 911 and local medic and ambulance was sent.  Patient was transported to local hospital to help with her hypotensive event.
10 days after dose 2 of Moderna (Feb 10, 2021), three fingers in each hand suffered trigger finger at exactly the same time.
Bright red discharge from vagina; This is a spontaneous report from a contactable consumer or other non hcp reported for herself. A 40-years-old non-pregnant female patient received BNT162B2 (BNT162B2, Pfizer-BioNTech COVID 19 vaccine, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Right on 06Aug2021 09:30 as dose1, single (age at vaccination 40 years) for covid-19 immunisation (At Pharmacy or Drug Store). The patient medical history was not reported. Concomitant medication included prednisone (other medications in two weeks) taken for an unspecified indication, start and stop date were not reported. The patient experienced bright red discharge from vagina on 08Aug2021 12:00. Patient was not received any treatment for the event. The outcome of the event was not recovered.   No follow-up attempts are possible. No further information is expected.
devel urticarial rash on face, trunk & extremities on 3JAN93;
Inflammation between her vertebrae; Stenosis; Arthritis; Flattening of the nerve; Weakness; Pain on fingers/Pain on arms; she had pain on her upper body (arms, shoulders, fingers); needle like feeling on her fingers,; ice coldness feeling on her fingers; Pain on shoulders; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Pain on shoulders), INTERVERTEBRAL DISC DISORDER (Inflammation between her vertebrae), STENOSIS (Stenosis), ARTHRITIS (Arthritis) and NERVE COMPRESSION (Flattening of the nerve) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hashimoto's disease, Penicillin allergy (Penicillin or any other penicillin derivatives) and Arthritis. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), LAMOTRIGINE (LAMICTAL), CALCIUM, VITAMIN C [ASCORBIC ACID], ASCORBIC ACID, CALCIUM, MINERALS NOS, RETINOL, TOCOPHERYL ACETATE, VITAMIN B NOS, VITAMINS NOS, ZINC (CENTRUM SILVER [ASCORBIC ACID;CALCIUM;MINERALS NOS;RETINOL;TOCOPHERYL ACETATE;VITAMIN B NOS;VITAMINS NOS;ZINC]) and BIOTIN for an unknown indication.    On 24-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Aug-2021, the patient experienced ARTHRALGIA (Pain on shoulders), INTERVERTEBRAL DISC DISORDER (Inflammation between her vertebrae), STENOSIS (Stenosis), ARTHRITIS (Arthritis), NERVE COMPRESSION (Flattening of the nerve), ASTHENIA (Weakness), PAIN IN EXTREMITY (Pain on fingers/Pain on arms), PAIN (she had pain on her upper body (arms, shoulders, fingers)), PARAESTHESIA (needle like feeling on her fingers,) and PERIPHERAL COLDNESS (ice coldness feeling on her fingers). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of 6 Tab once a day and LORAZEPAM (ATIVAN) at a dose of 1 Tab once a day. At the time of the report, ARTHRALGIA (Pain on shoulders), INTERVERTEBRAL DISC DISORDER (Inflammation between her vertebrae), STENOSIS (Stenosis), ARTHRITIS (Arthritis), NERVE COMPRESSION (Flattening of the nerve), ASTHENIA (Weakness), PAIN IN EXTREMITY (Pain on fingers/Pain on arms), PAIN (she had pain on her upper body (arms, shoulders, fingers)), PARAESTHESIA (needle like feeling on her fingers,) and PERIPHERAL COLDNESS (ice coldness feeling on her fingers) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Magnetic resonance imaging: abnormal (abnormal) inflammation between vertebrae (C1 to C7 and T2 to T3), stenosis.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient is allergic to latex, fragrance, aromatic soaps, detergents, furr,. fruits like mangoes and kiwi. Also had high ANA levels and considered to be immunocompromised.   This case was linked to MOD-2021-309590.
pt recv vax 9JUN94 & 15JUN94 devel a black & blue area above the smallpox inj site; f/u indicated that the pt was seen by pharmacy house physician;
pt recv vax & devel breakthrough chicken pox; the physician also reported additional pts who were vax w/ other lots of vax & devel breakthrough chickenpox;
Wheezing, tingley in left arm, numbness sensation like novocaine on left side of jaw, heart palpitations, aching between shoulder blades, headache
expired doses administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired doses administered) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired doses administered). On 19-Aug-2021, EXPIRED PRODUCT ADMINISTERED (expired doses administered) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: 800-900 (Inconclusive) antibody test was done on patient and antibody numbers were in the 800-900 range..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by reporter No treatment medications provided by the reporter.     This case was linked to (Patient Link).
Approx 24 hrs post immunization, swelling, warmth and redness at site injection R thigh. Placed ice with decreased swelling.
p/vax pt had been running a fever 100-103 c/o some cough, threw up x 2;started w/fever on 8/7-ran it until 8/12;8/12 T102.5 a;
Severe tremors in hands, arms, legs, torso, buttock, neck - onset was rapid, and once started they lasted for ~ 5 hours continuous non-stop violent tremors; and then again on and off for the next 10 hours Severe chills - it felt like there was ice inside my body
Acute diverticulitis requiring hospitalization twice (5/5-5/9/2022 and 5/26-5/30/2022)
Muscular pain Left Shoulder, body weakness, Lethargy, Limited range of motion/left arm, nausea, loss of appetite, dizziness, facial and upper body flushing
SHOULD HAVE RECEIVED BIVALENT BOOSTER BUT GOT REGULAR DOSE INSTEAD
I had red blotches on lower abdomen, upper thigh, breast, underarms, a beak; Reaction to vaccine -possible body redness; UTI; This is a spontaneous report from a contactable consumer (patient). A 69-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), intramuscular, administered in left arm on 17Mar2021 08:00 (Lot Number: EN6204) (at the age of 69-years-old) as dose 2, single for covid-19 immunisation. Medical history included gastrooesophageal reflux disease (GERD), osteoporosis (Recast infusion), supraventricular tachycardia, arthritis, gastroparesis, cholesterol, penicillin allergy and UTI (urinary tract infection). Patient's family medical history included parkinson's, dementia, stomach cancer, colon cancer. Concomitant medications included levofloxacin taken for urinary tract infection from 16Mar2021 to 19Mar2021; atorvastatin calcium (LIPITOL) taken for blood cholesterol from an unspecified start date and ongoing; omeprazole taken for gastrooesophageal reflux disease from an unspecified start date and ongoing; calcium taken for osteoporosis from an unspecified start date and ongoing; vitamin D3 taken for osteoporosis, start and stop date were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), intramuscular, administered in left arm on 24Feb2021 08:10 (Lot Number: EN6200) (at the age of 69-years-old) as dose 1, single for covid-19 immunisation. The patient previously took bactrim and experienced allergy. Two days after second vaccine on 19Mar2021, patient had red blotches on lower abdomen, upper thigh, breast, underarms, a beak. She also had a UTI (current condition) and thought she was having a reaction to levofloxacin. On 19Mar2021, patient had reaction to vaccine -possible body redness. The patient did not receive treatment for red blotches and body redness. Patient on unspecified date in 2021, patient had UTI. The patient received Macrobid orally for UTI from 20Sep2021 till 27Sep2021 as treatment. The outcome of red blotches and redness generalised was recovered in 2021 and outcome of urinary tract infection was unknown.  No follow-up attempts are needed. No further information is expected.
This spontaneous report was received from a pharmacist concerning a 75 year old female patient. There was no information about the patient's concurrent conditions, medical history or concomitant medication. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 for prophylaxis (dose, route of administration, lot number and expiration date were not reported). On an unknown date, the patient experienced a pain on an unspecified arm (pain in extremity) and cellulitis. The patient sought unspecified medical attention and was treated with clindamycin. The outcome of the pain in extremity and cellulitis and the causal relationship between the events and therapy with PNEUMOVAX 23 were not reported. Upon internal review the event cellulitis was considered to be medically significant.
Patient became very dizzy, pale, and nauseous after receiving vaccine, I had patient sit and elevate feet, also had patient drink some water. Patient came around in about 5-10 minutes. I had him stay for an additional 15 minutes and walk around for a few minutes and he felt fine after that. I also followed up that evening about 6 PM and patient was fine.
Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Rec'd Pfizer Vaccines 1/26/2021, 2/20/2021 and 9/13/2021. Prior hospitalization for bilateral community-acquired PNA and acute hypoxic respiratory failure from 4/4/2022 - 4/11/2022 at same facility and was Covid neg.  Presented to ED 5/1/2022 with c/o productive cough and SOB, and tested POSITIVE for COVID. Admitted w/acute on chronic hypoxemic resp failure due to Covid PNA, placed on BIPAP. Also found to have a RLL PE on CTA at presentation. Condition deteriorated despite tx w/vanc, dexamethasone, zinc sulfate, and ascorbic acid. Expired on 5/8/2022.
Patient reports mild symptoms after vaccination that went away after 2 days including nausea and vomiting. However, starting 04/28/21 patient began experiencing full body itching. The only recent change was immunization. Patient is unsure if vaccination is the cause of the itching but wanted to report just in case. Patient is without a primary care provider currently and went to an urgent care center after a sleepless night 04/30/21 due to itching. The urgent care prescribed something for the itching but patient didn't feel she was taken seriously with concerns about vaccination. Patient will try to follow up with previous primary care provider in the future.
On approximately 12/2/99, the pt had a pap smear as well as blood samples performed. The blood tests revealed elevated liver enzymes. The pt sought unspecified medical attention.
she is now having "pretty severe" diarrhea; This is a spontaneous report from a contactable Other Health Professional (Nurse, self-reported). A 39-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 13Apr2021 as SINGLE DOSE for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unspecified date the patient experienced she is now having "pretty severe" diarrhea. The clinical outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
4 minute Mild nose bleed.; This is a spontaneous report received from a contactable consumer, the patient. A 65-years-old unspecified aged patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6203) via an unspecified route of administration in the right arm on 08Mar2021 at 11:15 for COVID-19 immunisation. The patient medical history included hyperlipidemia, hypertension. The patient concomitant medication included Lisinopril (MANUFACTURER UNKNOWN), Amlodipine (MANUFACTURER UNKNOWN), Atorvastatin (MANUFACTURER UNKNOWN), Vit d3 (MANUFACTURER UNKNOWN) and coq1. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient been not tested for COVID-19. On 14Mar2021, at 20:30, on 6th day post vaccine the patient experienced spontaneous 4 minutes of mild nose bleed, it was his 1st occurrence in lifetime. No other sxs and he did not contact MD. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of nose bleed was recovered an unknown date.   No follow-up attempts possible. No further information expected.
diaphragmatic, low bp  95/53, dizziness, lightheartedness, tingling on arms and feet .
This spontaneous report as received from a pharmacist refers to a patient of unknown age. The patient had a history of dermatologic issue on the skin. No current conditions were reported. On an unknown date the patient was vaccinated with ZOSTAVAX (dose, route and frequency not reported) (lot # and exp. Date not reported). No co suspects or concomitant medications were reported. A pharmacist told the representative that on an unknown date the patient developed big red swollen spot after received a dose of ZOSTAVAX. The outcome of big red swollen spot is unknown. Additional information has been requested.
Inflammation and swelling of knees, fingers and wrists. Carpal Tunnel Syndrome. Has had surgery. Numbness and tingling in hands.
Mother notes fever with T Ax 101.5 and treated with wt. approp. TYLENOL. Exam on 7/14/10 (24 hours after shot) revealed T Ax 99.4 (40 min. after TYL). There was no other source of fever. The shot site was nl appearing.
No additional AE reported; VARIVAX had a temperature excursion on 10 OCT 2020 and was administered; This spontaneous report was received from an office manager, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, historical drugs, concurrent conditions, concomitant therapies, and previous drug reactions or allergies was not reported.       On 19-OCT-2020, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot number T012548), for prophylaxis  (dose, vaccination scheme frequency, route of administration and anatomical site of vaccination were not reported). No additional adverse events (AE) were reported.  The vaccine had a temperature excursion on 10-OCT-2020, being stored in temperature ranges of -14 degree Celsius (°C) to -10°C (-14.3°C) for 1 hour and 15 minutes and -9°C to -8°C (-9.3°C) for 32 minutes as recorded by a data logger. There was no previous temperature excursion reported.   Lot No. T012548 has been verified to be a valid lot number for varicella virus vaccine live (oka/merck) (VARIVAX), expiration date reported as 09-APR-2022 but upon internal validation established as 10-APR-2022.  This is one of several reports received from the same reporter.
Fever 101.4 x6 hours Headache Light headed and unsteady Fatigue All over muscle soreness and fatigue  Bone pain at elbows Achy eyes Brain fog
tingling sensation left arm; tingling sensation left fingers; tingling sensation spread to left side of neck; tingling sensation left face cheek; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling sensation left arm), PARAESTHESIA (tingling sensation left fingers), PARAESTHESIA (tingling sensation spread to left side of neck) and PARAESTHESIA (tingling sensation left face cheek) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced PARAESTHESIA (tingling sensation left arm), PARAESTHESIA (tingling sensation left fingers), PARAESTHESIA (tingling sensation spread to left side of neck) and PARAESTHESIA (tingling sensation left face cheek). On 27-Mar-2021, PARAESTHESIA (tingling sensation left arm), PARAESTHESIA (tingling sensation left fingers), PARAESTHESIA (tingling sensation spread to left side of neck) and PARAESTHESIA (tingling sensation left face cheek) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Arm became swollen. Site of injection was pink, warm and very painful. Swelling is down to her wrist today (11/12/2018) but pain is much better. No fever. Alternating ice/heat. TYLENOL for the pain. Keeping arm elevated as best as possible.
Polyuria, polydypsia, unconsolable crying, sensory integration problems, GI distress - Dx'ed with hypopituitarism.
I've been on a nocturnal schedule since the pandemic lockdowns began, so after my appointment for my vaccine, I ran some errands and went home to go to sleep. I woke up around midnight with an extremely sore arm just below the point of injection (like being punched in the arm for several hours, but no visible bruising, slight redness and swelling about the size of a 1/3 of a hard boiled egg). I also started to get a headache (I get headaches regularly with my menstrual cycle, but this was different, and my cycle ended a few days ago). The headache gradually got worse. I got the chills, not severe. I also had loose stool, again not severe enough to warrant medical attention. I took two off brand Advil liquigels, which reduced the swelling on my arm, and my headache lessened. Headache and loose stool persistent to today (two days after shot), however are significantly better than yesterday. Everything feels typical for what I was prepared to possibly expect, just wanted to report it, all the same.
pt recv vax 25OCT & pt attended party 26OCT96-5 people from that exposure reportedly devel chicken pox;pt devel clinical chicken pox 11 days from vax;
pt recv vax & approx 1 year following vax pt exp breakthrough chickenpox described as sporadic w/less than 50 lesions;tx w/Zovirax;
This case was reported by a consumer via call center representative and described the occurrence of chills in a 59-year-old female patient who received SHINGRIX for prophylaxis. On 21st June 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, less than a year after receiving SHINGRIX, the patient experienced chills, fatigue and muscle pain. On an unknown date, the outcome of the chills, fatigue and muscle pain were recovered/resolved. It was unknown if the reporter considered the chills, fatigue and muscle pain to be related to SHINGRIX. Additional details were provided as follows: The patient received her 1st dose of SHINGRIX on 21st June 2018. On Sunday, 5th August 2018, she received the 2nd dose because she was at the pharmacy where they were administering it and she could not remember when she got the 1st dose. For tolerance to next dose, refer case US2018GSK148701.
awoke 430 on 8APR seemed stiff, didn't move in sleep;had diff turning over & sitting up;subjective fever @ home;seen in clinic w/o fever;had only limp in lt leg where recv vax;d/c from clinic w/o further incident;
Patient was 11 years and 8 months at the time of  vaccine administration. Vaccine is indicated for 12 years and up only. No adverse reactions reported.
Flu like symptoms, aching, dizzy heart racing sev. hr after shot. Saw dr the next AM. who sent her to ER. DECADRON, morphine and LORTABS.
Hive like swelling around injection site; Hive like swelling around injection site; This is a spontaneous report from a contactable Consumer. This 14-year-old male consumer reported for himself that:  A 14-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Fc3182), via an unspecified route of administration in Arm Left on 27Aug2021 13:30 (at the age of 14-year-old) as DOSE 2, SINGLE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. The patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Fc3180), via an unspecified route of administration in Arm Left on 06Aug2021 (at the age of 14-year-old) as DOSE 1, SINGLE for covid-19 immunization. On 29Aug2021 patient experienced hive like swelling around injection site. Patient didn't received treatment for the events. The clinical outcome of the event was recovering.
pt recvd vax 10OCT94 that evening awoke w/sweating & pain & swelling in lt upper arm; seen in clinic again 11OCT94 redness & swelling 5" x 7" in lt upper arm, dec mobility in upper arm; t99.6; referral to primary hlth provider;
This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 04-DEC-2015 the patient was vaccinated with improperly stored MMR II (dose and route not reported, lot # L012482, expiration date: 10-APR-2017). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.